New Greek Ministry of Health measures 'cut down hope for patients'

The proposed new measures of the Ministry of Health prove to be disastrous for both the right of Greek patients to unhindered and fair access to the necessary treatments and for public health and the viability of the pharmaceutical industry. This was highlighted at a press conference held last week by the Hellenic Association of Pharmaceutical Companies (SFEE).

Against the background of an already ailing public health budget – public pharmaceutical expenditure in Greece is 50% of the European average – SFEE officials pointed to the risk of pharmaceutical poverty and to the devastating consequences of the new measures, which practically represent a threat from a humanitarian and social viewpoint.

Hamper access to innovative treatments